Otonomy Analyst Ratings
Otonomy Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/13/2022 | 317.01% | Piper Sandler | $3 → $0.5 | Downgrades | Overweight → Neutral |
08/02/2022 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
04/21/2022 | 4904.17% | Oppenheimer | $5 → $6 | Maintains | Outperform |
02/23/2021 | 4487.16% | HC Wainwright & Co. | $10 → $5.5 | Maintains | Buy |
07/07/2020 | 7406.26% | HC Wainwright & Co. | $8 → $9 | Maintains | Buy |
06/16/2020 | 7406.26% | Cantor Fitzgerald | $3 → $9 | Maintains | Overweight |
12/24/2019 | 6572.23% | Oppenheimer | → $8 | Initiates Coverage On | → Outperform |
08/29/2019 | 6572.23% | HC Wainwright & Co. | → $8 | Initiates Coverage On | → Buy |
11/15/2018 | 7406.26% | Cantor Fitzgerald | → $9 | Initiates Coverage On | → Overweight |
03/19/2018 | — | JP Morgan | Downgrades | Neutral → Underweight |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
2022 年 10 月 13 日 | 317.01% | 派珀·桑德勒 | 3 美元 → 0.5 美元 | 降級 | 超重 → 中性 |
08/02/2022 | — | HC Wainwright & Co. | 降級 | 買入 → 中性 | |
04/21/2022 | 4904.17% | 奧本海默 | 5 美元 → 6 美元 | 維持 | 跑贏大盤 |
2021 年 2 月 23 日 | 4487.16% | HC Wainwright & Co. | 10 美元 → 5.5 美元 | 維持 | 購買 |
07/07/2020 | 7406.26% | HC Wainwright & Co. | 8 美元 → 9 美元 | 維持 | 購買 |
06/16/2020 | 7406.26% | 坎託·菲茨傑拉德 | 3 美元 → 9 美元 | 維持 | 超重 |
12/24/2019 | 6572.23% | 奧本海默 | → 8 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
08/29/2019 | 6572.23% | HC Wainwright & Co. | → 8 美元 | 啓動覆蓋範圍開啓 | → 購買 |
11/15/2018 | 7406.26% | 坎託·菲茨傑拉德 | → 9 美元 | 啓動覆蓋範圍開啓 | → 超重 |
2018 年 3 月 19 日 | — | 摩根大通 | 降級 | 中性 → 體重不足 |
Otonomy Questions & Answers
Otonomy 問題與解答
The latest price target for Otonomy (NASDAQ: OTIC) was reported by Piper Sandler on October 13, 2022. The analyst firm set a price target for $0.50 expecting OTIC to rise to within 12 months (a possible 317.01% upside). 3 analyst firms have reported ratings in the last year.
派珀·桑德勒於2022年10月13日公佈了Otonomy(納斯達克股票代碼:OTIC)的最新目標股價。該分析公司將目標股價設定爲0.50美元,預計OTIC將在12個月內上漲至0.50美元(可能上漲317.01%)。去年有3家分析公司公佈了評級。
The latest analyst rating for Otonomy (NASDAQ: OTIC) was provided by Piper Sandler, and Otonomy downgraded their neutral rating.
Otonomy(納斯達克股票代碼:OTIC)的最新分析師評級由派珀·桑德勒提供,Otonomy下調了中性評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Otonomy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Otonomy was filed on October 13, 2022 so you should expect the next rating to be made available sometime around October 13, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Otonomy的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月進行一次評級,因此每家公司每年應獲得4個評級。Otonomy的最後一次評級是在2022年10月13日提交的,因此您應該預計下一個評級將在2023年10月13日左右公佈。
While ratings are subjective and will change, the latest Otonomy (OTIC) rating was a downgraded with a price target of $3.00 to $0.50. The current price Otonomy (OTIC) is trading at is $0.12, which is out of the analyst's predicted range.
儘管評級是主觀的,並將發生變化,但最新的Otonomy(OTIC)評級被下調,目標股價爲3.00美元至0.50美元。Otonomy(OTIC)當前的交易價格爲0.12美元,超出了分析師的預測區間。